日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study

根据同源重组缺陷状态分层的三阴性乳腺癌患者接受基于艾立布林的新辅助化疗的长期疗效：随机JBCRG-22研究的结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-026-07917-5
Masuda, Norikazu; Yasojima, Hiroyuki; Bando, Hiroko; Yamanaka, Takashi; Shigematsu, Hideo; Takahashi, Masato; Nagai, Shigenori E; Ito, Mitsuya; Aruga, Tomoyuki; Tokiwa, Mariko; Imoto, Shigeru; Nakamura, Rikiya; Ishiguro, Hiroshi; Kawabata, Hidetaka; Saji, Shigehira; Haga, Hironori; Morita, Satoshi; Toi, Masakazu
BCR
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Venlafaxine reduces hot flashes in hormone receptor-positive breast cancer patients receiving tamoxifen: a prospective single-arm, open-label trial

文拉法辛可减轻接受他莫昔芬治疗的激素受体阳性乳腺癌患者的潮热症状：一项前瞻性单臂开放标签试验

期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-026-01828-5
Sato, Riko; Kamohara, Rena; Matsuo, Tomohei; Sawa, Aya; Okazaki, Mai; Hashimoto, Sachie; Iguchi-Manaka, Akiko; Hara, Hisato; Doki, Kosuke; Mukai, Yuji; Homma, Masato; Ishii, Ryota; Shimada, Kensuke; Bando, Hiroko
信号转导
免疫/内分泌
乳腺癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Reactive oxygen species generation by photothermal effects of adhesive near-infrared agents on the plasma membrane.

近红外粘合剂对血浆膜的光热效应产生活性氧。

期刊:Journal of Clinical Biochemistry and Nutrition
影响因子:1.7
doi:10.3164/jcbn.25-113
Fujiwara Saori, Yoshitomi Toru, Kawazoe Naoki, Chen Guoping, Bando Hiroko, Hara Hisato, Matsui Hirofumi
发育与干细胞
发表日期：2026
文献求助 收藏

Tumor-expressed GPNMB orchestrates Siglec-9(+) TAM polarization and EMT to promote metastasis in triple-negative breast cancer

肿瘤表达的GPNMB调控Siglec-9(+) TAM极化和EMT，从而促进三阴性乳腺癌的转移

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2503081122
Dang Cao, Thuy Linh; Kawanishi, Kunio; Hashimoto, Sachie; Hengphasatporn, Kowit; Nagai-Okatani, Chiaki; Kimura, Takaharu; Abdelaziz, Mohammed; Shiratani, Rie; Poullikkas, Thanasis; Azmi, Nuriza Ulul; Baba, Masaki; Okita, Yukari; Watanabe, Yukihide; Bando, Hiroko; Yamazaki, Satoshi; Shigeta, Yasuteru; Kuno, Atsushi; Kato, Mitsuyasu
信号转导
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Non-cancer risks among female breast cancer survivors: a matched cohort study in Japan

日本一项针对女性乳腺癌幸存者的非癌症风险匹配队列研究

期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2025.101519
Kawamura, Chitose; Bhaskaran, Krishnan; Konishi, Takaaki; Sagara, Yasuaki; Bando, Hiroko; Shinozaki, Tomohiro; Nojiri, Shuko; Adomi, Motohiko; Wong, Angel Y S; Tamiya, Nanako; Iwagami, Masao
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancer

帕博西尼用于可手术、激素受体阳性乳腺癌女性患者的新辅助治疗

期刊:Endocrine-Related Cancer
影响因子:4.6
doi:10.1530/ERC-24-0353
Ueno, Takayuki; Chow, Louis W C; Han, Wonshik; Huang, Chiun Sheng; Mann, G Bruce; Morita, Satoshi; Haga, Hironori; Fakhrejahani, Elham; Kobayashi, Takayuki; Bando, Hiroko; Inoue, Kenichi; Tokiwa, Mariko; Suwa, Hirofumi; Aruga, Tomoyuki; Minamiguchi, Sachiko; Yamada, Yosuke; Tanabe, Yuko; Takada, Masahiro; Yamashita, Toshinari; Iwata, Hiroji; Chung, Chi-Feng; Takahara, Sachiko; Tokunaga, Eriko; Imoto, Shigeru; Lee, Eun Sook; Sagara, Yasuaki; Kim, Jee Hyun; DeBoer, Richard H; Kim, Hyun-Ah; Lai, Hung Wen; Hou, Ming Feng; White, Michelle; Umeyama, Yoshiko; Toi, Masakazu
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Refining compression therapy for the prevention of chemotherapy-induced peripheral neuropathy in breast cancer patients: a sub-analysis of patient-reported discomfort and usability

改进用于预防乳腺癌患者化疗引起的周围神经病变的压力疗法：患者报告的不适感和可用性的亚组分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14921-3
Okazaki, Mai; Ueda, Aya; Iguchi-Manaka, Akiko; Mathis, Bryan J; Shimada, Kensuke; Machino, Takeshi; Yamada, Takeshi; Bando, Hiroko
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer.

乳腺癌中 ESR1 和 PIK3CA 公共新抗原的 HLA II 类限制性 T 细胞表位

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13992-6
Ando Yukari, Miyadera Hiroko, Bando Hiroko, Hashimoto Sachie, Noguchi Emiko, Hara Hisato
细胞生物学
乳腺癌
发表日期：2025
文献求助 收藏

Correction: Real‑world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first‑ or second‑line treatment for hormone receptor-positive, HER2‑negative advanced or metastatic breast cancer

更正：来自日本的真实世界证据表明，接受 CDK4/6 抑制剂联合内分泌治疗作为激素受体阳性、HER2 阴性晚期或转移性乳腺癌一线或二线治疗的患者的生存结果和治疗顺序

期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-025-01736-0
Yoshinami, Tetsuhiro; Takano, Yuko; Ozaki, Yukinori; Kajiwara, Yukiko; Yamamoto, Mitsugu; Watanabe, Ken-Ichi; Tsukabe, Masami; Fujisawa, Fumie; Nagai, Shigenori E; Shibata, Nobuhiro; Oshiro, Chiya; Bando, Hiroko; Tsunoda, Nobuyuki; Yamagami, Kazuhiko; Koizumi, Kei; Takada, Masahiro; Toriguchi, Naoko; Sekine, Nobuyuki; Kawaguchi, Tsutomu; Saji, Shigehira; Sagara, Yasuaki; Morita, Satoshi; Masuda, Norikazu
CDK4
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

来自日本的真实世界证据表明，接受 CDK4/6 抑制剂联合内分泌治疗作为激素受体阳性、HER2 阴性晚期或转移性乳腺癌一线或二线治疗的患者的生存结果和治疗顺序

期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-025-01713-7
Yoshinami, Tetsuhiro; Takano, Yuko; Ozaki, Yukinori; Kajiwara, Yukiko; Yamamoto, Mitsugu; Watanabe, Ken-Ichi; Tsukabe, Masami; Fujisawa, Fumie; Nagai, Shigenori E; Shibata, Nobuhiro; Oshiro, Chiya; Bando, Hiroko; Tsunoda, Nobuyuki; Yamagami, Kazuhiko; Koizumi, Kei; Takada, Masahiro; Toriguchi, Naoko; Sekine, Nobuyuki; Kawaguchi, Tsutomu; Saji, Shigehira; Sagara, Yasuaki; Morita, Satoshi; Masuda, Norikazu
CDK4
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏